New Zoetis Drug Could Could Provide a Boost to Pet Care ETF

The ProShares Pet Care ETF (CBOE: PAWZ), the first and still the only dedicated pet care ETF, has plenty of favorable tailwinds. Another one may be arriving in the form of regulatory approval of Simparica Trio, a canine drug made by PAWZ holding Zoetis (NYSE: ZTS). Shares of Zoetis accounted for...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.